Bioprocessing Solutions for Biotech

On this page:

Advancing innovation across biotech workflows

Biotech teams often balance ambitious development goals with limited resources while working to keep programs on track. Early research, process development, and scale-up must progress smoothly as methods evolve and data is generated to support future cGMP expectations. Connected biotech bioprocessing solutions help bring these steps into a clearer sequence for reduced handoff friction and consistent performance as teams advance toward key milestones.

Support your efforts to reach milestones fast

Early-stage development depends on reliable insights that guide the next experimental or operational decision. Tight timelines, shifting protocols, and variability during scale-up can create delays or require rework. Scalable, data-informed tools help refine methods, support reproducibility, and maintain project momentum. When development begins with systems that transition smoothly to larger studies, teams can move with greater confidence toward their next milestone. As priorities shift and data emerges, teams often need the flexibility to adjust methods without losing momentum.

Solutions that support evolving early-stage workflows

With evolving targets, changing timelines, and ongoing methods of refinement, early-stage workflows can benefit from a bioprocessing solution for biotech that adapts as development progresses. Thermo Fisher Scientific offers solutions designed to support this flexibility from media and supplements to purification tools and analytical resources, allowing teams to adjust conditions, compare approaches, and build processes that remain viable as programs advance.
 

Collaborate with confidence through dedicated support

Help minimize bottlenecks early in development by collaborating with field application scientists and technical specialists. Address problems, adjust methods, and optimize processes as they mature, allowing teams to progress quickly with fewer interruptions.

Prepare for regulatory and commercial production

Let us help you avoid delays during the transition to cGMP conditions with clear documentation, consistent raw materials, and traceable workflows that reduce uncertainty as requirements tighten. Structured processes, verification of resources, and quality documentation help teams incorporate compliance into development.
 

Solutions across modalities and applications


Modalities, such as monoclonal antibodies (mAbs), vaccines, messenger RNA (mRNA), antibody-drug conjugates (ADCs), cell therapies, and gene therapies, often encounter different challenges as they move from early studies to scale-up. Flexible bioprocessing solutions support these varied applications, helping teams adapt methods as their pipelines expand.
 

Optimize performance with integrated solutions

Integrating connected bioprocessing solutions early helps reduce variability and guide decisions as methods mature. Our solutions work together across upstream and downstream steps to support reproducible performance and scalable process optimization.

Bioprocessing products

Maintain consistent performance and steady scale-up as workflows advance toward manufacturing with Gibco media, chromatography resins, single-use systems, process liquids, and more.

Bioprocessing services

Enhance workflows with services for buffer and media preparation, raw material sourcing and supply, pharmaceutical analytics, and more, to help teams address scale-up requirements and stay aligned with cGMP expectations. 

Build sustainable and scalable bioprocesses

Strengthen operational efficiency and resource management by integrating sustainable materials, energy-efficient process design, and regional manufacturing into your workflows. These actions help reduce transport impact, enhance supply continuity, and create a clearer path for long-term scalability as development expands.

Solutions across modalities and applications


Modalities, such as monoclonal antibodies (mAbs), vaccines, messenger RNA (mRNA), antibody-drug conjugates (ADCs), cell therapies, and gene therapies, often encounter different challenges as they move from early studies to scale-up. Flexible bioprocessing solutions support these varied applications, helping teams adapt methods as their pipelines expand.
 

Supporting customers that drive innovation

Productivity, consistency, and scalable development are priorities shared across the bioprocessing landscape. Thermo Fisher supports these needs across sectors, working to advance therapies. Learn more about the industries we serve.

Biopharma

Bioprocessing solutions enable biopharma teams to enhance efficiency, maintain quality, and mitigate risk throughout cGMP production. 
 

CDMO

Integrated solutions help contract development and manufacturing organizations (CDMOs) maintain consistency across client programs, support clear technology transfer, and manage scale-up with predictable performance.

Resources and insights for biotech innovators


As methods evolve, biotech teams benefit from practical, detailed guidance. Case studies, webinars, and technical notes highlight common upstream, downstream, and analytical challenges, helping teams refine decisions and prepare for later development stages.
 

Power progress in biotech workflows

 

Discover Thermo Fisher bioprocessing solutions for biotech. We offer catalog and custom services, professional expertise, and technical support.

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.